WALTHAM, Mass., Nov. 19 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the US market for reprocessed electrophysiology diagnostic catheters will grow at a rate of over 15% through 2014. MRG's new US Markets for Electrophysiology Mapping and Ablation Devices 2010 report finds that although reprocessed catheters have existed for a number of years, it is only recently that this device type has begun to play a larger role in the electrophysiology diagnostic market.
Several key events helped pave the way for reprocessed devices to account for a growing portion of the electrophysiology diagnostic catheter market. In January 2008, the US Government Accountability Office (GAO) released a report concluding that there was no evidence to suggest that reprocessed single-use devices create an elevated health risk for patients. In March of the same year, Massachusetts' State Legislature Public Health Joint Committee voted not to report favorably on bills that would require hospitals to receive patient consent before using reprocessed devices. Both of these events will help to reinforce the acceptance of reprocessed devices among health care providers and drive growth in the use of the reprocessed electrophysiology diagnostic catheters.
As large hospital group purchasing organizations (GPOs) such as ProvSource continue to sign on to supply contracts with commercial reprocessors like Ascent Healthcare Solutions, the market will continue to expand. With usage of diagnostic reprocessed catheters growing, suitability for recycling will become an increasingly important factor in hospital purchasing and stocking decisions.
"The economic climate and resultant budgetary constraints for hospitals are central drivers of the reprocessed catheter market," says Dan Whalen, Analyst at MRG. "Although safety issues were important
|SOURCE Millennium Research Group|
Copyright©2009 PR Newswire.
All rights reserved